Cargando…

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset

Detalles Bibliográficos
Autores principales:	Russo, Roberto, Gasparini, Giulia, Cozzani, Emanuele, D’Agostino, Federica, Parodi, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895245/ https://www.ncbi.nlm.nih.gov/pubmed/35251024 http://dx.doi.org/10.3389/fimmu.2022.834316

Ejemplares similares

May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022)

Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
por: Russo, Roberto, et al.
Publicado: (2020)

Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
por: Cozzani, Emanuele, et al.
Publicado: (2021)

Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022)

Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report
por: Herzum, Astrid, et al.
Publicado: (2022)

Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons
por: Gasparini, Giulia, et al.
Publicado: (2023)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Chilblain-like Lesions after COVID-19 Vaccination: A Case Series
por: RUSSO, Roberto, et al.
Publicado: (2022)

Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights
por: D’Astolto, Roberto, et al.
Publicado: (2023)

Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
por: Russo, Roberto, et al.
Publicado: (2022)

Considerations on inhibition of IL‐23 in psoriatic women of childbearing potential
por: Russo, Roberto, et al.
Publicado: (2021)

Self‐resolving bullous pemphigoid induced by cemiplimab
por: Molle, Mattia Fabio, et al.
Publicado: (2022)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Guselkumab‐associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature
por: Burlando, Martina, et al.
Publicado: (2021)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects
por: Cozzani, Emanuele, et al.
Publicado: (2014)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

The Role of Mast Cells in Autoimmune Bullous Dermatoses
por: Yu, Xinhua, et al.
Publicado: (2018)

Humoral Epitope Spreading in Autoimmune Bullous Diseases
por: Didona, Dario, et al.
Publicado: (2018)

Serological Diagnosis of Autoimmune Bullous Skin Diseases
por: Saschenbrecker, Sandra, et al.
Publicado: (2019)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
por: Merli, Martina, et al.
Publicado: (2023)

Reply to “The SARS-COV Pandemic Does Not Absolve From Solid Medical Trade”
por: Okor, Ivana, et al.
Publicado: (2021)

Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80
por: Burlando, Martina, et al.
Publicado: (2021)

Retrospective analysis of autoimmune bullous diseases in Middle Franconia
por: Sollfrank, Lukas, et al.
Publicado: (2023)

Understanding CD4(+) T cells in autoimmune bullous diseases
por: Lee, A Yeong, et al.
Publicado: (2023)

Cutaneous reactions to COVID‐19 vaccine at the dermatology primary care
por: Burlando, Martina, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
por: Parodi, Aurora, et al.
Publicado: (2020)

Papulopustular Rosacea Treated With Ivermectin 1% Cream: Remission of the Demodex Mite Infestation Over Time and Evaluation of Clinical Relapses
por: Trave, Ilaria, et al.
Publicado: (2022)

The SARS-CoV-2 Pandemic Does Not Absolve From Solid Medical Trade
por: Finsterer, Josef, et al.
Publicado: (2021)

Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review
por: Edwards, Gareth, et al.
Publicado: (2019)

Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses
por: Cao, Tianyu, et al.
Publicado: (2019)

Generalized Tinea Incognito Developing from “Mask Tinea”
por: Russo, Roberto, et al.
Publicado: (2022)

Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study
por: Burlando, Martina, et al.
Publicado: (2023)

New‐onset bullous pemphigoid and flare of pre‐existing bullous pemphigoid after the third dose of the COVID‐19 vaccine
por: Bardazzi, Federico, et al.
Publicado: (2022)

Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder
por: Aashish, et al.
Publicado: (2022)

Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications
por: Cozzani, Emanuele, et al.
Publicado: (2021)

Amelanotic acral melanoma mimicking a plantar wart
por: Cozzani, Emanuele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_972rrtr0juufood5c9unudlgkr